Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
2003 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Phototherapy, Photochemotherapy, and Bone Marrow Transplantation
1993
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Colorectal cancer statistics, 2023
2023 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Global Cancer Statistics, 2002
2005 Standout
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
2002
Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias
1995
Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival
1989
Atopic dermatitis
2015 Standout
Cancer Statistics, 2009
2009 Standout
Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology
2000
Cancer Statistics, 2006
2006 Standout
Cancer Statistics, 2008
2008 Standout
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
2001
Effect of pegylation on pharmaceuticals
2003 Standout
Further studies of the defective stimulus‐response coupling for the oxidative burst in neutrophils in polycythemia vera
1991
Molecular evolution of acute myeloid leukaemia in relapse: unstable N‐ras and FLT3 genes compared with p53 gene
1999
Pegaspargase: An Alternative?
1997
Chlorambucil in Indolent Chronic Lymphocytic Leukemia
1998
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Treatment of early chronic lymphocytic leukemia: Intermittent chlorambucil versus observation
1988
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
1991
Pathophysiology and therapy of pruritus in allergic and atopic diseases
2010
Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival
2004
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy
1991
Cancer Statistics, 2005
2005 Standout
Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia
2001
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis
1999
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron
1987
In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor
2000 StandoutNobel
Impaired Platelet Binding of Fibrinogen Due to a Lower Number of GPIIB/IIIA Receptors in Polycythemia Vera
1998 StandoutNobel
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Platelet Density Distribution in Essential Thrombocythemia
2010 StandoutNobel
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
2007 Standout
Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
2009 Standout
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study
2002
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
A selective inhibitor of the p110δ isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16
2006
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: a review
2007 Standout
Cancer Statistics, 2007
2007 Standout
Cancer Statistics, 2010
2010 Standout
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
1991
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
2000 Standout
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
1989 Standout
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Aggressive Plasma Cell Myeloma
1981
Clustering of aberrations to specific chromosomes in human neoplasms
2009
Clustering of aberrations to specific chromosomes in human neoplasms
2009
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis [see comments]
1992
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS IN THE ACCELERATED PHASE OF CHRONIC GRANULOCYTIC LEUKAEMIA
1982
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Fludarabine: a new agent with major activity against chronic lymphocytic leukemia
1989
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment
1996 Standout
Gleevec: Prototype or Outlier?
2004 StandoutNobel
The role of microRNA genes in papillary thyroid carcinoma
2005 Standout
The Clonal Evolution of Tumor Cell Populations
1976 StandoutScience
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
1985 StandoutNature
Phase I trial of recombinant interferon gamma in cancer patients.
1986
Molecular Characterization of Novel Reciprocal Translocation t(6;14) in an Epstein-Barr Virus-Transformed B Cell Precursor
1987 StandoutNobel
Indications for Marrow Transplantation
1984 StandoutNobel
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
1999 Standout
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
1999
Chronic Myelogenous Leukemia — New Concepts
1981
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
2001 Standout
Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia.
2005
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
1997 StandoutScience
Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion.
2003
Guidelines for Treatment of Candidiasis
2004 Standout
GENETICS OF MYELOID LEUKEMIAS
2002
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see comments]
1993
Chronic Lymphocytic Leukemia
1984
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia
2001
The generation of human long-term marrow cultures from marrow depleted of Ia (HLA-DR) positive cells
1984
Works of RT Silver being referenced
Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E
1982
Combination chemotherapy for terminal-phase chronic granulocytic leukemia: cancer and leukemia group B studies
1980
Variant ph1 translocation in chronic myeloid leukemia [letter]
1979
A new treatment for polycythemia vera: recombinant interferon alfa [see comments]
1990
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia
1994
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia
1994
Variant ph1 translocation in chronic myeloid leukemia [letter]
1979
Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia
1977
Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B
1984